The molecular workshop
A road can be rerouted. Here, the object being rerouted also changes shape.
Joining two designs
Researchers combined structural features of NN703 and ipamorelin and tested the hybrids in rat pituitary cells and for growth-hormone release in swine. Reintroducing ipamorelin's C-terminal features into the NN703 design produced unexpectedly potent compounds in both settings. The C-terminus is one end of the molecular chain.
That reversal delights me. A design altered for oral access still had something to gain from features of its starting molecule. The result makes the chemistry feel less like a march toward one ideal structure and more like a workshop where discarded pieces return to the bench.
The hybrid study tested hormone-releasing activity in cells and swine. Its finding concerns those compounds in those tests.
Restricting the terminal shape
A study of conformational restriction in the C-terminal region explored how limiting a compound's possible shapes affected potency. Derived compounds achieved activity in rat pituitary-cell tests, and the research reported 40% oral bioavailability with a growth-hormone response in swine.
That combination of findings appeals to my mechanical imagination: changing the freedom of one end of a chain can change how the whole compound behaves. I'd judge the reach of that principle from the measurements for each candidate. The study concerns a set of engineered secretagogues.
Absorption, potency and selectivity
The oral series studied in dogs and the hybrid tests in cells and swine place different demands on a candidate. Passing into blood, stimulating growth-hormone release and retaining a desirable hormonal profile each require measurements of their own.
I give the chemists credit for working on several constraints at once. The next stop, hormone selectivity, is where the attractive word selective becomes more demanding than a family resemblance.